|1 Table of Contents 3
|1.1 List of Tables 17
|1.2 List of Figures 18
2 Introduction 20
2.1 What Is This Report About? 20
2.2 Oncology Market Segmentation 20
2.3 Definitions of Markets Covered in the Report 22
3 Oncology Market, North America 29
3.1 Oncology Market, North America, Revenue ($m), 2018-2033 29
3.2 Oncology Market, North America, Revenue ($m), 2018-2033 31
3.3 Oncology Market, North America, Volume (Units), 2018-2033 34
3.4 Oncology Market, North America, Volume (Units), 2018-2033 36
3.5 Oncology Market, North America, Company Share by Revenue ($m), 2024 39
4 Oncology Market, Canada 41
4.1 Oncology Market, Canada, Revenue ($m), 2018-2033 41
4.1.1 ALK Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 44
4.1.2 BCR-ABL Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 46
4.1.3 BRAF Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 48
4.1.4 BRCA Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 50
4.1.5 Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 52
4.1.6 EGFR Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 54
4.1.7 HER2 Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 56
4.1.8 KRAS Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 58
3.2 Oncology Market, Canada, Volume (Units), 2018-2033 60
4.2.1 ALK Tests Market, Canada, Volume (Units), by Segment, 2018-2033 63
4.2.2 BCR-ABL Tests Market, Canada, Volume (Units), by Segment, 2018-2033 65
4.2.3 BRAF Tests Market, Canada, Volume (Units), by Segment, 2018-2033 67
4.2.4 BRCA Tests Market, Canada, Volume (Units), by Segment, 2018-2033 69
4.2.5 Colorectal Cancer Screening Tests Market, Canada, Volume (Units), by Segment, 2018-2033 71
4.2.6 EGFR Tests Market, Canada, Volume (Units), by Segment, 2018-2033 73
4.2.7 HER2 Tests Market, Canada, Volume (Units), by Segment, 2018-2033 75
4.2.8 KRAS Tests Market, Canada, Volume (Units), by Segment, 2018-2033 77
4.3 Oncology Market, Canada, Average Price ($) , 2018-2033 79
4.4 Oncology Market, Canada, Company Share by Revenue ($m), 2024 83
5 Oncology Market, Mexico 85
5.1 Oncology Market, Mexico, Revenue ($m), 2018-2033 85
5.1.1 ALK Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 88
5.1.2 BCR-ABL Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 90
5.1.3 BRAF Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 92
5.1.4 BRCA Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 94
5.1.5 Colorectal Cancer Screening Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 96
5.1.6 EGFR Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 98
5.1.7 HER2 Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 100
5.1.8 KRAS Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 102
5.2 Oncology Market, Mexico, Volume (Units), 2018-2033 104
5.2.1 ALK Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 107
5.2.2 BCR-ABL Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 109
5.2.3 BRAF Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 111
5.2.4 BRCA Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 113
5.2.5 Colorectal Cancer Screening Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 115
5.2.6 EGFR Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 117
5.2.7 HER2 Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 119
5.2.8 KRAS Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 121
5.3 Oncology Market, Mexico, Average Price ($) , 2018-2033 123
5.4 Oncology Market, Mexico, Company Share by Revenue ($m), 2024 126
6 Oncology Market, United States 128
6.1 Oncology Market, United States, Revenue ($m), 2018-2033 128
6.1.1 ALK Tests Market, United States, Revenue ($m), by Segment, 2018-2033 131
6.1.2 BCR-ABL Tests Market, United States, Revenue ($m), by Segment, 2018-2033 133
6.1.3 BRAF Tests Market, United States, Revenue ($m), by Segment, 2018-2033 135
6.1.4 BRCA Tests Market, United States, Revenue ($m), by Segment, 2018-2033 137
6.1.5 Colorectal Cancer Screening Tests Market, United States, Revenue ($m), by Segment, 2018-2033 139
6.1.6 EGFR Tests Market, United States, Revenue ($m), by Segment, 2018-2033 141
6.1.7 HER2 Tests Market, United States, Revenue ($m), by Segment, 2018-2033 143
6.1.8 KRAS Tests Market, United States, Revenue ($m), by Segment, 2018-2033 145
6.2 Oncology Market, United States, Volume (Units), 2018-2033 147
6.2.1 ALK Tests Market, United States, Volume (Units), by Segment, 2018-2033 150
6.2.2 BCR-ABL Tests Market, United States, Volume (Units), by Segment, 2018-2033 152
6.2.3 BRAF Tests Market, United States, Volume (Units), by Segment, 2018-2033 154
6.2.4 BRCA Tests Market, United States, Volume (Units), by Segment, 2018-2033 156
6.2.5 Colorectal Cancer Screening Tests Market, United States, Volume (Units), by Segment, 2018-2033 158
6.2.6 EGFR Tests Market, United States, Volume (Units), by Segment, 2018-2033 160
6.2.7 HER2 Tests Market, United States, Volume (Units), by Segment, 2018-2033 162
6.2.8 KRAS Tests Market, United States, Volume (Units), by Segment, 2018-2033 164
6.3 Oncology Market, United States, Average Price ($) , 2018-2033 166
6.4 Oncology Market, United States, Company Share by Revenue ($m), 2024 169
7 Overview of Key Companies in United States, Oncology Market 171
7.1 Exact Sciences Corp 171
7.1.1 Company Overview 171
7.2 Agilent Technologies Inc 171
7.2.1 Company Overview 171
7.3 F. Hoffmann-La Roche Ltd 171
7.3.1 Company Overview 171
7.4 Abbott Laboratories 171
7.4.1 Company Overview 171
7.5 Qiagen NV 172
7.5.1 Company Overview 172
7.6 Danaher Corp 172
7.6.1 Company Overview 172
7.7 Guardant Health Inc 172
7.7.1 Company Overview 172
7.8 Thermo Fisher Scientific Inc 172
7.8.1 Company Overview 172
7.9 BioGenex Laboratories Inc 173
7.9.1 Company Overview 173
7.10 Bio-Techne Corp 173
7.10.1 Company Overview 173
8 Recent Developments 174
8.1 Corporate Communications 174
8.1.1 Jun 10, 2025: Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors 174
8.1.2 May 29, 2025: Outcomes4Me Secures $21M in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care 174
8.1.3 Apr 22, 2025: New York Cancer & Blood Specialists Adopt the Deepscribe Ambient Operating System 175
8.1.4 Apr 17, 2025: Wake Radiology UNC Health REX Suits Up For Participation In 2025 Susan G. Komen Triangle Race For The Cure 175
8.1.5 Mar 18, 2025: NeoGenomics Appoints Warren Stone as President & Chief Operating Officer 176
8.1.6 Mar 03, 2025: Clinical Pediatric Cancer Lab at UC Santa Cruz is Cleared to Accept and Test Patient Samples 176
8.1.7 Feb 19, 2025: Thermo Fisher Scientific Elects New Director to Board 179
8.1.8 Feb 18, 2025: Industry Leaders Join Mizzou Cybersecurity Advisory Board 179
8.1.9 Feb 04, 2025: Groundbreaking Alzheimer's and Cancer Studies Receive $7.2M Boost 179
8.1.10 Jan 15, 2025: The University of Florida Appoints Waste Pro Vice President to Advisory Board 180
8.1.11 Jan 13, 2025: Cellworks’ Computational Biosimulation Lab Secures CLIA Certification to Advance Personalized Therapy Decision Support 180
8.1.12 Jan 08, 2025: Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies 181
8.1.13 Jan 08, 2025: Cofactor Genomics Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test 181
8.1.14 Dec 20, 2024: MD Anderson Receives Nearly $8 Million in CPRIT Funding for Screening and Early Detection Programs, Faculty Recruitment 182
8.1.15 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 182
8.1.16 Dec 06, 2024: Dr.William K.Oh appointed medical director of Smilow Cancer Hospital at Greenwich and director of precision medicine at Yale Cancer Center 182
8.1.17 Nov 11, 2024: Geron Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development 183
8.1.18 Nov 06, 2024: PrognomiQ secures funding to advance lung cancer detection test 184
8.1.19 Nov 04, 2024: PurpleLab Presents: A Unique Approach to Precision Medicine: Racial Disparities in Non-Small Cell Lung Cancer (NSCLC) Biomarker Testing 184
8.1.20 Oct 24, 2024: Roberto A. Mignone Joins Guardant Health Board of Directors 185
8.1.21 Oct 22, 2024: Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS 186
8.1.22 Oct 15, 2024: EpiVario Announces Appointment of Chris Cashman to the Board of Directors 186
8.1.23 Oct 08, 2024: Opthea Announces New Senior Hires 187
8.1.24 Oct 07, 2024: Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development 188
8.1.25 Oct 03, 2024: Successful 2024 ISO 13485 Certification Maintenance Strengthening Ikonisys’ Strong Market Position and Growth Potential 188
8.1.26 Sep 24, 2024: The Oncology Institute announces chief financial officer transition 189
8.1.27 Sep 23, 2024: OPKO Health’s ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer 189
8.1.28 Sep 10, 2024: Tyra Biosciences Appoints Doug Warner as Chief Medical Officer 190
8.1.29 Sep 09, 2024: Geron Appoints Jim Ziegler as Chief Commercial Officer 190
8.1.30 Sep 04, 2024: Veracyte Adds Brent Shafer and Tom Miller to Board of Directors 191
8.1.31 Sep 03, 2024: City of Hope Appoints Simon Nazarian as Chief Digital and Technology Officer to Drive Innovation and Digital Transformation 191
8.1.32 Aug 23, 2024: Caris Life Sciences Announces Appointment of Dave Fredrickson to Board of Directors 192
8.1.33 Aug 14, 2024: Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research 192
8.1.34 Aug 07, 2024: Biden-harris Administration Awards Nearly $9 Million To Improve Access To Cancer Screening And Connections To Follow-up Treatment In Underserved Communities To Deliver On Biden Cancer Moonshot Goals 193
8.2 Financial Announcements 193
8.2.1 Jun 26, 2025: Labcorp to Announce Second Quarter Financial Results on July 24, 2025 193
8.2.2 Apr 29, 2025: Co-Diagnostics Announces First Quarter 2025 Earnings Release Date and Webcast 194
8.2.3 Apr 22, 2025: Quest Diagnostics Announces Results for Q1 Ended March 31, 2025 194
8.2.4 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results 194
8.2.5 Apr 08, 2025: NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 195
8.2.6 Apr 03, 2025: Revvity to Hold Earnings Call on Monday, April 28, 2025 195
8.2.7 Mar 31, 2025: Labcorp to Announce First Quarter Financial Results on April 29, 2025 195
8.2.8 Mar 20, 2025: Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results 195
8.2.9 Mar 05, 2025: Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025 197
8.2.10 Feb 27, 2025: Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update 197
8.2.11 Feb 25, 2025: Nuvectis Pharma Reports 2024 Financial Results and Business Highlights 198
8.2.12 Feb 18, 2025: NeoGenomics Reports Fourth Quarter and Full Year 2024 Results 199
8.2.13 Feb 14, 2025: Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update 199
8.2.14 Feb 13, 2025: Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results 201
8.2.15 Feb 10, 2025: Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025 202
8.2.16 Feb 07, 2025: MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference 202
8.2.17 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 203
8.2.18 Jan 31, 2025: Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 204
8.2.19 Jan 29, 2025: NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 205
8.2.20 Jan 16, 2025: Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 205
8.2.21 Jan 12, 2025: Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance 205
8.2.22 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 205
8.2.23 Jan 02, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 205
8.2.24 Dec 19, 2024: Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025 206
8.2.25 Dec 16, 2024: StageZero Life Sciences Reports Q3 2024 Results and Operational Update 206
8.2.26 Nov 28, 2024: MedMira Reports FY2024 Fourth Quarter and Year End Financial Results 207
8.2.27 Nov 14, 2024: Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update 208
8.2.28 Nov 10, 2024: RadNet Posts Financial Results for Q3 of 2024 209
8.2.29 Nov 07, 2024: Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024 210
8.2.30 Nov 06, 2024: Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance 211
8.2.31 Nov 04, 2024: Revvity Announces Financial Results for the Third Quarter of 2024 212
8.2.32 Oct 31, 2024: Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update 213
8.2.33 Oct 23, 2024: Thermo Fisher Scientific Announces Q3 2024 Financial Results 214
8.2.34 Oct 16, 2024: Lilly Confirms Date and Conference Call for Third-Quarter 2024 Financial Results Announcement 215
8.2.35 Oct 15, 2024: Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024 216
8.2.36 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results 216
8.2.37 Oct 07, 2024: Revvity to Hold Earnings Call on Monday, November 4, 2024 216
8.2.38 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 216
8.2.39 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024 216
8.2.40 Oct 01, 2024: Merck to Hold Third-Quarter 2024 Sales and Earnings Conference Call Oct. 31 217
8.2.41 Oct 01, 2024: StageZero Life Sciences Announces Q2 2024 Financial Results and Operational Update 217
8.2.42 Sep 24, 2024: Labcorp to Announce Third Quarter Financial Results on October 24, 2024 218
8.2.43 Sep 23, 2024: Amgen to Host Conference Call to Discuss New Topline Data in Inflammation and Rare Disease 218
8.2.44 Sep 12, 2024: Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024 218
8.2.45 Aug 15, 2024: Memorial Sloan Kettering Cancer Center Issues Statement on Second Quarter 2024 Financial Results 219
8.2.46 Aug 07, 2024: Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance 219
8.2.47 Aug 06, 2024: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance 220
8.2.48 Aug 06, 2024: Halozyme Reports Second Quarter 2024 Financial And Operating Results 221
8.2.49 Aug 01, 2024: Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 223
8.2.50 Jul 31, 2024: Exact Sciences Announces Second-Quarter 2024 Results 223
8.2.51 Jul 30, 2024: Panbela to Host Second Quarter 2024 Earnings Conference Call on August 13, 2024 224
8.2.52 Jul 16, 2024: RadNet Announces Date of its Second Quarter 2024 Financial Results Conference Call 224
8.2.53 Jul 09, 2024: Revvity to Hold Earnings Call on Monday, July 29, 2024 224
8.2.54 Jul 09, 2024: NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024 224
8.2.55 Jul 08, 2024: Exact Sciences Schedules Second Quarter 2024 Earnings Call 225
8.2.56 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024 225
8.2.57 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024 225
8.3 Government and Public Interest 225
8.3.1 May 08, 2025: Guardant Health to Participate in Upcoming Investor Conferences 225
8.3.2 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference 226
8.3.3 Apr 14, 2025: ACR Statement on JAMA CT Scan Radiation Study (Smith-Bindman, et al) 226
8.3.4 Apr 09, 2025: ASCO Updates Guidelines for Pleural Mesothelioma 226
8.3.5 Mar 25, 2025: Nearly Half of Women With Ovarian Cancer Are Not Receiving Critical Genetic Testing 227
8.3.6 Mar 25, 2025: Brain Imaging Plus Virtual Reality Shows Promise for Effectively Managing Cancer Pain 228
8.3.7 Feb 24, 2025: NeoGenomics to Participate in Upcoming Investor Conferences 228
8.3.8 Feb 24, 2025: Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025 229
8.3.9 Feb 21, 2025: Geron to Participate at Upcoming Investor Conferences in March 2025 229
8.3.10 Feb 07, 2025: MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference 229
8.3.11 Feb 04, 2025: Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference 229
8.3.12 Jan 08, 2025: Unique Stanford Medicine-Designed AI Predicts Cancer Prognoses, Responses to Treatment 229
8.3.13 Jan 07, 2025: Developing Drugs for Optical Imaging 231
8.3.14 Dec 12, 2024: Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 231
8.3.15 Dec 10, 2024: Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines 231
8.3.16 Nov 27, 2024: Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference 231
8.3.17 Nov 22, 2024: Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference 232
8.3.18 Nov 19, 2024: Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference 232
8.3.19 Nov 18, 2024: Statement on Passage of Diagnostic and Supplemental Imaging Legislation in Massachusetts 232
8.3.20 Nov 14, 2024: Merck to Participate in the Jefferies London Healthcare Conference 232
8.3.21 Nov 11, 2024: Nordic Bioscience Receives Letter of Support from the FDA for the CPa9-HNE Biomarker in Inflammatory Bowel Diseases 232
8.3.22 Oct 14, 2024: Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit 233
8.3.23 Oct 08, 2024: T2 Biosystems to Host Business Update Call on October 10, 2024 233
8.3.24 Oct 04, 2024: Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference 233
8.3.25 Sep 30, 2024: Study Advocates for Alternative Biopsy Approach to Detecting Prostate Cancer 233
8.3.26 Sep 11, 2024: Merck to Participate in the Bank of America 2024 Global Healthcare Conference 234
8.3.27 Aug 29, 2024: NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference 234
8.3.28 Aug 29, 2024: Merck to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference 234
8.3.29 Jul 13, 2024: New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies 235
8.4 Other Significant Developments 235
8.4.1 Jun 25, 2025: Ambry Genetics’ CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing 235
8.4.2 Jun 23, 2025: Icon Group and Varian Expand Global Partnership To Deliver Advanced Cancer Technology Across the UK 236
8.4.3 Jun 03, 2025: Aegis Sciences Announces Updates for Novel Psychoactive Substances (NPS) Testing 237
8.4.4 May 27, 2025: University of Houston Awarded $3M to Launch Cancer Biomarker Facility for Immunotherapy Research 237
8.4.5 May 19, 2025: Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology 238
8.4.6 Apr 24, 2025: Stellaromics Announces First Deployment of Pyxa Platform in Europe 238
8.4.7 Apr 15, 2025: Carti Cancer Center Deploys Deepscribe’s Ambient Operating System for Oncology 239
8.4.8 Apr 01, 2025: Covera Health Launches Protect Her – A Breakthrough AI Solution to Advance Early Detection in Women's Health 239
8.4.9 Mar 25, 2025: Government of Guyana, Mount Sinai Health System and Hess Corporation Announce Five-Year Extension of National Healthcare Initiative 240
8.4.10 Mar 24, 2025: ZERO Prostate Cancer Applauds Virginia's Landmark Decision to Ensure Prostate Cancer Screening at No Cost 241
8.4.11 Mar 18, 2025: Real-World Patients with Cancer Show Lower Survival Times and Treatment-Associated Survival Benefits Compared to Those Included in RCTs 242
8.4.12 Mar 05, 2025: Clear Diagnostix Unveils AI-Powered Solutions to Revolutionize Cancer Patient Care 243
8.4.13 Mar 03, 2025: TruScreen – Key Markets Update and Revenue Guidance 244
8.4.14 Feb 27, 2025: Avitia Launches AI-Powered Platform for Rapid & Point-Of-Care Cancer Testing 245
8.4.15 Feb 21, 2025: The OhmX RAMP UP Grant Awarded to 15 Laboratories to Advance Genomic Research 246
8.4.16 Feb 20, 2025: Cancer Check Labs Expands Early Detection Cancer Testing to Pennsylvania, Maryland, and Rhode Island 246
8.4.17 Feb 20, 2025: VSee Health Receives $560K Contract to Deploy Virtual Command Center for Major Oncology Network 247
8.4.18 Feb 19, 2025: Illumina Unveils First-Of-Its-Kind Spatial Transcriptomics Technology 247
8.4.19 Feb 19, 2025: New Test for Cervical Cancer Tackles Healthcare Inequalities 249
8.4.20 Feb 13, 2025: $2.5 Million Grant Awarded to Indiana University School of Medicine, Beckman Coulter Life Sciences to Expand Leukemia and Lymphoma Testing in Africa 249
8.4.21 Jan 21, 2025: New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide 250
8.4.22 Jan 09, 2025: Agendia Provides Review of Successful 2024 251
8.4.23 Jan 08, 2025: Foresight Diagnostics Provides 2025 Outlook and 2024 Year in Review 252
8.4.24 Jan 07, 2025: Erisyon Awarded $2.2M Grant to Develop Diagnostic for Immuno-Oncology Treatment Selection 253
8.4.25 Jan 06, 2025: PhenoVista Biosciences Partners with NETRI to Expand Organ-on-Chip Service Offerings for Drug Development 254
8.4.26 Dec 17, 2024: ISS National Lab-Sponsored Projects on Cancer, Neurodegenerative Conditions, and More Return From Space Station 254
8.4.27 Dec 05, 2024: Foundation Medicine Awards Grants to Organizations Addressing Disparities in Biomarker Testing for Breast and Prostate Cancer 255
8.4.28 Dec 05, 2024: UNC Researchers Awarded up to $10M to Leverage Data Science to Accelerate Cancer Diagnosis and Optimize Delivery of Precision Oncology 255
8.4.29 Dec 03, 2024: Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award 256
8.4.30 Nov 29, 2024: Government of Canada Invests in Breast Cancer Research and Public Awareness 257
8.4.31 Nov 14, 2024: Brain Tumor Funders' Collaborative Announces New Grant Opportunity to Support Studies on Liquid Biopsy in Primary Brain Tumors 257
8.4.32 Nov 12, 2024: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax’s CE IVD-Certified Technology in Oncological Diagnostics and Organ Transplant Safety 258
8.4.33 Nov 06, 2024: Dovetail Genomics Secures $2M Sbir Grant To Develop High-Throughput Linkprep Solutions for Oncology Applications 259
8.4.34 Nov 04, 2024: PurpleLab Presents: A Unique Approach to Precision Medicine: Racial Disparities in Non-Small Cell Lung Cancer (NSCLC) Biomarker Testing 259
8.4.35 Oct 31, 2024: Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution 260
8.4.36 Oct 31, 2024: CURE51 Chooses 10X Genomics Visium HD for New Drug Discovery Initiative 261
8.4.37 Oct 30, 2024: Tom Knight To Lead Optinosis as Founder and CEO 261
8.4.38 Oct 22, 2024: Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS 262
8.4.39 Oct 22, 2024: Previse Receives $1.8m Research Grant from the National Institutes of Health to Further Pipeline Diagnostic Test 262
8.4.40 Oct 22, 2024: Telix Spins off Rhine Pharma to Expand Global Access to Radiopharmaceuticals 262
8.4.41 Oct 21, 2024: GE HealthCare Announces CareIntellect for Oncology, Harnessing AI to Give Clinicians an Easy Way to See the Patient Journey in a Single View 263
8.4.42 Oct 16, 2024: Arcadia Strengthens Healthcare Data Platform with Faster, Cost-Effective Interoperability Solutions 264
8.4.43 Sep 26, 2024: Sinai Health Receives $1-Million Gift to Transform Diagnostic Approaches and Fight Cancer Through Digital Pathology 265
8.4.44 Sep 19, 2024: Markey Researchers Awarded $6.8 Million to Help Others Replicate Kentucky’s Lung Cancer Screening Success 266
8.4.45 Sep 19, 2024: Dana-Farber Cancer Institute Partners with Clinical.ly to Enhance Regulatory Operations with eReg Solutions 267
8.4.46 Sep 19, 2024: Georgia Cancer Center Using AI to Diagnose, Treat Lung Cancer 267
8.4.47 Sep 12, 2024: BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions 268
8.4.48 Sep 11, 2024: Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees, Including First Recipients in India and the Netherlands 268
8.4.49 Sep 11, 2024: Global Ultrasound Institute Unveils Groundbreaking Liver Essentials Course and Fellowship Program 269
8.4.50 Sep 10, 2024: UMass Amherst Researcher to Use Wearable Sleep Trackers, AI to Predict Early Signs of Alzheimer’s 271
8.4.51 Sep 05, 2024: American Cancer Society Launches the National Prostate Cancer Roundtable to Address an Alarming Rise in Diagnoses 271
8.4.52 Sep 02, 2024: EDX Medical partners with Caris Life Sciences for molecular profiling 272
8.4.53 Aug 22, 2024: Baylor College of Medicine Receives More Than $17 Million From CPRIT 272
8.4.54 Aug 20, 2024: Dr.Tanya Stoyanova Receives Grant to Develop New Radiopharmaceuticals for Cancer 273
8.4.55 Aug 19, 2024: ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology 273
8.4.56 Aug 14, 2024: Ways2Well Selects Cancer Check Labs as its Exclusive Provider of Early Cancer Detection Testing 274
8.4.57 Aug 13, 2024: ARPA-H Lends Award to Project to Develop Precision Surgical Tools for Cancer Care 275
8.4.58 Aug 12, 2024: Roswell Park Indigenous Cancer Screening/Navigation Success Reaches New Mexico with BMS Foundation Grant 275
8.4.59 Aug 05, 2024: 10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases 276
8.4.60 Aug 01, 2024: Paige Changes the Game for Cancer Research, Diagnostics and Drug Development by Open-Sourcing Virchow and PRISM, the First Million Slide Foundation Model Suite 276
8.4.61 Jul 25, 2024: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results 277
8.4.62 Jul 25, 2024: FAU Researcher Lands Grant for Personalized Cancer Radiation Therapy 278
8.4.63 Jul 09, 2024: New Co-Star Receptor Shows Promise Treating Cancers in Laboratory Study 278
8.4.64 Jul 08, 2024: Monmouth Medical Center Introduces Three Innovative Technologies in Lung Cancer Diagnosis and Treatment 279
8.4.65 Jul 05, 2024: Easier, Shorter Radiation Treatment for Early Stage Breast Cancer Now Offered at University of Maryland Shore Regional Health Cancer Center 280
8.4.66 Jul 02, 2024: Immunovia’s New Lab Staffed and Operational After Rapid Implementation 281
8.5 Product News 281
8.6 Strategy And Business Planning 387
9 Appendix 430
9.1 Research Methodology 431
9.1.1 Coverage 431
9.1.2 Secondary Research 431
9.1.3 Primary Research 431
9.1.4 Market Modeling and Forecasting 432
9.1.5 Company Share Analysis 433
9.1.6 Benchmarking 434
9.2 GlobalData Consulting 435
9.3 Contact Us 435
9.4 Disclaimer 435
